The Topical Wound Agents Market is anticipated to reach US$ 3.0 million in sales by 2032, up from US$ 1.5 million in 2022, with a CAGR of 6.6% over the forecast period.
The global topical wound agents market has witnessed robust growth due to rising prevalence of chronic wounds in all age groups. Topical wound agents market is a witness to the presence of many local players which hold a huge market share in the Topical Wound Agents Market. There are huge opportunities for the manufacturers due to the large number of patients suffering from both acute and chronic wounds.
The key players in the topical wound agents market are mainly focused on R&D to accelerate the development of novel drugs to increase their market share. Improved accessibility to healthcare services along with increasing awareness in patient population is expected to boost the growth of the topical wound agents market in developing economies. The topical wound agents market is anticipated to grow with double digit CAGR during the forecast period. Topical wound agents are medical preparations used to treat dermatological injuries. Topical wound agents are mainly formulated into emulsions, creams, oils, spray and others.
A wide variety of agents are used for the management of both acute and chronic wounds. Topical wound agents are mainly used for controlling inflammation, infection and pain. NSAIDs & Analgesics were used to treat inflammation & pain. However, wound healing is a complex progress and is affected by both intrinsic and extrinsic factors. Infection delays the healing process and increases the risk of infections. To control the infection, mainly disinfectants are used and they are active against disease-causing microorganisms and include antiseptics and antibiotics.
Antiseptics are broad-spectrum antimicrobials used to treat intact skin or open wounds. Antibiotics are agents that kill or inhibit the growth of microorganisms and are used against specific cells (narrow broad spectrum). Antibiotics are more susceptible to bacterial resistance and require a continuous change in treatment regimen. Topical antibiotics are more advantageous than systemic antibiotics due to fewer side effects and limited dosage errors.
Topical Wound Agents Market: Key Participants
Some of the key participants in the Topical Wound Agents market include Teva Pharmaceutical Industries Ltd., Novartis AG, Pfizer Inc., Johnson & Johnson, Mylan N.V., AstraZeneca Plc. and others. Companies are focused on formulating new dosage forms to increase the adoption of topical wound agents.
Topical Wound Agents Market: Segmentation
Segmentation of Topical Wound Agents Market based on Drug Type
- NSAIDS
- Antiseptics
- Antibiotics
- Others
Segmentation of Topical Wound Agents Market based on Dosage Forms
- Creams
- Lotions
- Powders
- Emulsions
- Gels
- Others
Segmentation of Topical Wound Agents Market based on Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies/Drugstores
- E-Commerce
Browse More@ https://www.futuremarketinsights.com/reports/topical-wound-agents-market
The global Psoriasis Drugs Market size is expected to value at USD 21.4 billion by 2022. The market is subject to witness a substantial growth due to the rise in the number of reimbursement policies and schemes, adoption of highly advanced diagnostic tools, increase in awareness among individuals and adoption of latest technologies in healthcare sector.
Globally, the market is predicted to grow at CAGR of 9.3% in forecast period, providing numerous opportunity for market players to invest for research and development in the psoriasis drugs market.
Psoriasis are majorly categorized into five types such as plaque, guttate, inverse, pustular and erythrodermic. Such factors are playing vital role for growth of the psoriasis drugs market in recent years. Psoriasis drugs consists of topical agents and systemic agents.
